ArticleHaematologica2020

Venetoclax in combination with carfilzomib, doxorubicin and dexamethasone restores responsiveness in an otherwise treatment-refractory multiple myeloma patient.

Sarolta Bojtine Kovacs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.